Chemoinformaics analysis of 2-Ethyl-6-methylpyrazine
| Molecular Weight | 122.171 | nRot | 1 |
| Heavy Atom Molecular Weight | 112.091 | nRig | 1 |
| Exact Molecular Weight | 122.084 | nRing | 1 |
| Solubility: LogS | -6.476 | nHRing | 1 |
| Solubility: LogP | 7.363 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 20.5579 |
| nHD | 0 | BPOL | 12.3121 |
| QED | 0.232 |
| Synth | 1.822 |
| Natural Product Likeliness | 0.73 |
| NR-PPAR-gamma | 0.527 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.917 |
| MDCK | 0.0000109 |
| BBB | 0.61 |
| PPB | 0.952923 |
| VDSS | 3.62 |
| FU | 0.013835 |
| CYP1A2-inh | 0.176 |
| CYP1A2-sub | 0.187 |
| CYP2c19-inh | 0.337 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.106 |
| CYP2c9-sub | 0.946 |
| CYP2d6-inh | 0.412 |
| CYP2d6-sub | 0.086 |
| CYP3a4-inh | 0.225 |
| CYP3a4-sub | 0.037 |
| CL | 3.669 |
| T12 | 0.107 |
| hERG | 0.416 |
| Ames | 0.018 |
| ROA | 0.016 |
| SkinSen | 0.978 |
| Carcinogencity | 0.096 |
| EI | 0.937 |
| Respiratory | 0.963 |
| NR-Aromatase | 0.155 |
| Antiviral | No |
| Prediction | 0.906072 |